This novel insight into the MCPIP1-induced anti-inflammatory activity implies that melittin might be a pioneering therapeutic agent for ischemic stroke and potentially for other neuroinflammatory diseases. The gene discussed is ZC3H12A; the disease is ischemic stroke.